No Data
No Data
Unusual Options Activity: JNJ, CSCO and Others Attract Market Bets, JNJ V/OI Ratio Reaches 153.8
EST Jul 5th Morning Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.Of
What's Going On With Johnson and Johnson Shares Friday?
Johnson and Johnson (NYSE:JNJ) shares are trending on Friday. In the last week, the pharmaceutical company announced positive results from two clinical trials and authorization from Health Canada for
J&J (JNJ) Trades Below 200 & 50-Day Moving Averages: Buy the Dip?
ohnson & Johnson’s (JNJ Quick QuoteJNJ - Free Report) stock has been trading below its 200-day and 50-day moving averages since the end of June. On Jul 3, the stock’s closing price of $145.69 was below its 50-day moving average of $147.61 and the 200-day moving average of 151.95.
Johnson & Johnson's bispecific antibody drug talquetamab has been approved for sale in South Korea.
On July 2, Johnson & Johnson's (JNJ.US) South Korea company announced that its bispecific antibody drug Talquetamab has been approved for launch in South Korea.
Johnson & Johnson Receives Canadian Approval for Rybrevant in First-line NSCLC
U.S. Indicated Dividend Payments Rose in Q2 Led by Alphabet's Initiation
Indicated dividend net changes for U.S. domestic common stocks rose $16.05B in Q2, as compared to a $16.03B increase in the prior quarter, according to the data from S&P Dow Jones Indices.